Beyond the symptom control



The recommended initial dose of CinnoRA® for adult patients with crohn’s disease, ulcerative colitis and hidradenitis suppurativa is 160 mg which can be given as four 40 mg injections on day 1 or split as two 40 mg injections per day over two consecutive days.


Baseline monitoring:

Monitor latent TB screening prior to initiating, HBV screening prior to initiating.

LFT and CBC with differential prior to initiating, Signs or symptoms of active infection, including tuberculosis.


Ongoing monitoring:

Monitor latent TB during therapy (Consider at least a yearly PPD); Periodic CBC with differential; HBV carriers (during and for several months following therapy); LFT*;

*For other two drugs, the decision should be made by physician based on the case.

Signs or symptoms of active infection, including tuberculosis (during, and following therapy);



Periodic history, physical examination and monitoring for improvement of signs, symptoms, or worsening of heart failure, signs and symptoms of hypersensitivity reaction; symptoms of lupus-like syndrome; signs or symptoms of malignancy (including periodic skin examination) or signs or symptoms of demyelinating disorders (eg, multiple sclerosis, Guillain-Barré syndrome) are recommended while on treatment.


Tell your doctor about all of your health conditions, including if you:

-Have an infection, are being treated for infection, or have symptoms of an infection

-Are scheduled for major surgery

-Have TB or living in an endemic region or have a contact with a patient with TB.

-Have Hepatitis B or have a history of Hepatitis B

-Have or have had cancer

-A nervous system disease such as multiple sclerosis or Guillain-Barre syndrome

- Have or had heart failure

-Have diabetes

 -Are allergic to any CinnoRA® or any ingredients of it.

-Are pregnant, planning to be pregnant, breastfeeding or planning to breastfeed

-Have recently received or are scheduled to receive e vaccine.

-Know the medicines you take. Keep a list of your medicines with you to show your doctor and pharmacist each time you get a new medicine.


Always inform your doctor if you are pregnant or planning to become pregnant, breastfeeding or planning to breastfeed before using any medicine. This drug should only be used during pregnancy if the benefit outweighs the risk to the fetus.